Loading clinical trials...

COMPLETEDNA

Plantar Cutaneous Sensory Stimulation in Patients With Diabetic Neuropathy

Effects of Plantar Cutaneous Sensory Stimulation on Foot Tactile Sensitivity, Postural Control, and Spatiotemporal Gait Parameters in Patients With Diabetic Neuropathy

NCT06292468•Riphah International University

View on ClinicalTrials.gov

Summary

To determine the effects of plantar cutaneous sensory stimulation on foot tactile sensitivity, postural control, and spatiotemporal gait parameters in patients with diabetic neuropathy.

Eligibility

Age

45 - 67 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Age ranged between 45-67 years.
•Both male and female genders are included.
•DM for the past 7 years.
•Scored \> 2/13 on the Michigan Neuropathy Screening Instrument (MNSI) questionnaire including at least two DPN symptoms.
•Scored \>1/10 on MNSI physical assessment including impaired vibration perception

Exclusion Criteria

•Loss of protective foot sensation (defined as a lack of response to the monofilament of the sensory evaluation instrument).
•Comorbidities include visual impairment, cerebrovascular accident, orthopedic trauma, labyrinthitis, peripheral vascular disease, and heart failure.
•Foot ulcers, orthopedic or surgical problems in a lower limb, other neurological impairment.
•Use of assistive devices for ambulation.
•Inability to walk independently with or without an assistive device.
•Receiving any structured supervised physiotherapy intervention

Locations (2)

PhysioFit

Faisalabad, Punjab Province, Pakistan

Allied Hospital Faisalabad.

Faisalābad, Punjab Province, Pakistan

Key Dates

Start Date

July 7, 2023

Primary Completion Date

August 18, 2023

Completion Date

September 18, 2023

Last Updated

March 5, 2024

Enrollment

ACTUAL participants

Conditions

Diabetic Neuropathies

Interventions

Traditional physical therapy

OTHER

Plantar cutaneous sensory stimulation

OTHER

Integrated Oral Care Intervention for Xerostomia in Diabetes Patients

NCT07425275

Diabetes MellitusDiabetic Neuropathies

View study

RECRUITING

Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY OF LIFE Questionnaire

NCT06483620

Diabetic NeuropathiesDiabetic Peripheral Neuropathy

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 5, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Plantar Cutaneous Sensory Stimulation in Patients With Diabetic Neuropathy

Inclusion Criteria

Exclusion Criteria

Integrated Oral Care Intervention for Xerostomia in Diabetes Patients

Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY OF LIFE Questionnaire

Additional Hyperbaric Oxygen After Lower Extremity Amputation

Effects of Customized Silicone Digital Orthoses in People With Diabetic Neuropathy

Digital Heath Integration With Neuromodulation Therapies on Diabetic Neuropathy

Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland